EW Stock — Edwards Lifesciences Corp.

Edwards Lifesciences Corp. (EW)

Updated October 16, 2026.

EW is a Stock. Total return is 6198.2% over the past 26.6 years, 5496.5 points ahead of SPY at 701.7%.

Edwards Lifesciences Corporation develops and sells medical devices and technologies for treating advanced cardiovascular diseases, with a focus on minimally invasive transcatheter heart valve replacement and repair products sold globally under brands including Edwards SAPIEN, PASCAL, EVOQUE, and INSPIRIS. The company distributes its products through direct sales forces and independent distributors. Edwards Lifesciences does not currently have an established regular distribution schedule.

EW performance versus SPY

Price and return data through 2026-10-16.

Total return is 6198.2% over the past 26.6 years, 5496.5 points ahead of SPY at 701.7%. Over the past year its total return — price change plus distributions reinvested — is 19.2%. Its deepest 1-year drawdown was 13.2%.

EW key facts

Asset type

Stock

Asset class

Equity

Inception date

03/27/2000

Distribution frequency

None

Last close

$86.60 (as of 2026-10-16)

Market cap

$49,916,240,000

Average volume

4007412.0

Beta

0.864

Payout ratio

0.0%

P/E ratio

50.94

Forward P/E

25.641

EPS

$1.70

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

EW risks and drawbacks

The deepest 1-year drawdown on record here is 13.2%.

Who may consider EW — and who may not

It is a weaker fit for investors who need monthly cash flow (EW does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on EW

• All tickers starting with E

Tagged: Healthcare.

Frequently asked questions